tiprankstipranks
Trending News
More News >
Cardio Diagnostics Holdings Inc. (CDIO)
:CDIO
US Market
Advertisement

Cardio Diagnostics Holdings Inc.

Compare
257 Followers

CDIO Stock Chart & Stats

$4.28
-$0.13(-15.46%)
At close: 4:00 PM EST
$4.28
-$0.13(-15.46%)

Cardio Diagnostics Holdings News

CDIO FAQ

What was Cardio Diagnostics Holdings Inc.’s price range in the past 12 months?
Cardio Diagnostics Holdings Inc. lowest stock price was $3.22 and its highest was $53.10 in the past 12 months.
    What is Cardio Diagnostics Holdings Inc.’s market cap?
    Cardio Diagnostics Holdings Inc.’s market cap is $7.48M.
      When is Cardio Diagnostics Holdings Inc.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Cardio Diagnostics Holdings Inc.’s earnings last quarter?
      Currently, no data Available
      Is Cardio Diagnostics Holdings Inc. overvalued?
      According to Wall Street analysts Cardio Diagnostics Holdings Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Cardio Diagnostics Holdings Inc. pay dividends?
        Cardio Diagnostics Holdings Inc. does not currently pay dividends.
        What is Cardio Diagnostics Holdings Inc.’s EPS estimate?
        Cardio Diagnostics Holdings Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Cardio Diagnostics Holdings Inc. have?
        Cardio Diagnostics Holdings Inc. has 1,763,129 shares outstanding.
          What happened to Cardio Diagnostics Holdings Inc.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Cardio Diagnostics Holdings Inc.?
          Currently, no hedge funds are holding shares in CDIO

          Company Description

          Cardio Diagnostics Holdings Inc.

          Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
          Similar Stocks
          Company
          Price & Change
          Follow
          Theriva Biologics
          Galmed Pharmaceuticals
          Entero Therapeutics
          Cyclerion Therapeutics
          Silexion Therapeutics

          Ownership Overview

          4.56%1.38%0.09%92.92%
          4.56%
          Insiders
          0.09% Other Institutional Investors
          92.92% Public Companies and
          Individual Investors

          Options Prices

          Currently, No data available
          ---
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis